Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Hers vs Mochi Health

Hers and Mochi Health sell different medications; this is what separates them.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Hers logo

Hers

7.0
★★★★☆3.5/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Hers →
VS
Mochi Health logo

Mochi Health

6.6
★★★☆☆3.3/5

Best for: coaching bundled into the price rather than sold separately

Visit Mochi Health →

If you are choosing between Hers and Mochi Health, price alone will not settle it. Hers leads our six-part score, 7.0 to 6.6.

Hers vs Mochi Health price

Hers publishes $199 a month. Mochi Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.

Medications and formats

Hers lists semaglutide and tirzepatide; Mochi Health does not name its drug.

On format, Hers prices compounded injections and brand-name pens, while Mochi Health posts no priced format.

If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.

Where each one treats patients

Hers lists 50 states, and Mochi Health lists 15 states.

They overlap in 15 states. Hers alone covers 35 states, including Alaska, Alabama, Arkansas and California.

Pricing

Hers

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)

Mochi Health

Starting dose (membership $79/mo + medication)Compounded
$139/mo
semaglutide

Membership is $79/mo plus $60/mo for compounded semaglutide. The $39 membership Mochi leads with is a first-month rate for new customers; the standard rate is $79 per month after that. The $60 is a 'starting at' price that varies by dose, the lowest rung rather than a flat rate. $99 is shown struck through beside it.

Starting dose (membership $79/mo + medication)Compounded
$169/mo
tirzepatide

Membership is $79/mo plus $90/mo for compounded tirzepatide. The $39 membership is a first-month promotional rate; the standard rate is $79. The $90 is a 'starting at' price that varies by dose. $199 is shown struck through beside it.

What each price covers

Hers' price also covers the medication itself, which Mochi Health does not claim.

Mochi Health's price also covers the clinician visit and coaching, which Hers does not claim.

Hers is silent on shipping and lab work.

Mochi Health is silent on shipping and lab work.

That matters most for the drug: unless Mochi Health confirms otherwise, budget for medication on top of its listed price.

Hers

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

Mochi Health

Covered by the monthly price

Medication

Charged on top

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

In the price

Where each one scores higher

Overall, Hers scores 7.0 and Mochi Health 6.6 out of 10.

Hers is stronger on accessibility (10.0 vs 4.4).

Mochi Health is stronger on support (4.0 vs 3.0).

Value, effectiveness, user experience and trust & safety are within half a point.

How we score

Hers

7.0/10

Overall

Mochi Health

6.6/10

Value25%

3.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.5A
vs
B
8.5

Accessibility10%

10.0A
vs
B
4.4

Support10%

3.0A
vs
B
4.0

FDA warning letters

Neither Hers nor Mochi Health has an FDA warning letter on record with us.

Features & Coverage

FeatureHersMochi Health
Starting Price$199/moNot published
Features2 features✓3 features
States Available✓5015
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Hers

Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.

Read our full Hers review →

About Mochi Health

Mochi Health is an obesity medicine telehealth seller running aggressively priced compounded GLP-1 programs.

Read our full Mochi Health review →

Pros & Cons

Hers

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states
  • We found no FDA warning letters issued to Hers

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Mochi Health

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes clinician visits and coaching
  • We found no FDA warning letters issued to Mochi Health

Watch-outs

  • Not included in the monthly price: medication
  • Serves only 15 states, so check that yours is one of them
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Hers

Hers wins this one, 7.0 to 6.6, above all for coverage in all 50 states, which most sellers will not confirm. Mochi Health fits better if coaching bundled into the price rather than sold separately is your priority.

Choose Hers if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.

Choose Mochi Health if…

You want coaching bundled into the price rather than sold separately.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.6

Willow

Seeing what it charges before you answer any medical questions

6.5

Sesame Care

Oral orforglipron alongside the injectables

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

Hers vs Mochi Health: FAQ

Only Hers publishes a price ($199 a month). Mochi Health quotes after sign-up.
No. Hers lists semaglutide and tirzepatide; Mochi Health lists no named drug.
Hers: 50 states against 15, with 15 in common.
Only Hers includes the medication itself. Only Mochi Health includes the clinician visit and coaching.
Hers has none. Mochi Health has none.
No. Neither Hers nor Mochi Health pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.